{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:07:11Z","timestamp":1792408031271,"version":"4.4.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.ccl.2007.09.005","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:57:32Z","timestamp":1196960252000},"page":"507-522","source":"Crossref","is-referenced-by-count":5,"title":["Applying Hypertension Guidelines to Reduce the Burden of Heart Failure"],"prefix":"10.1016","volume":"25","author":[{"given":"Ragavendra R.","family":"Baliga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ccl.2007.09.005_bib1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ccl.2007.09.005_bib2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","article-title":"Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study","volume":"287","author":"Vasan","year":"2002","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.ccl.2007.09.005_bib3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ccl.2007.09.005_bib4","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","article-title":"Heart disease and stroke statistics: 2007 update. a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"115","author":"Rosamond","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2007.09.005_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-138-1-200301070-00006","article-title":"Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study","volume":"138","author":"Haider","year":"2003","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ccl.2007.09.005_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jama.281.7.634","article-title":"Increased pulse pressure and risk of heart failure in the elderly","volume":"281","author":"Chae","year":"1999","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccl.2007.09.005_bib7","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0002-9149(01)01974-9","article-title":"Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program","volume":"88","author":"Vaccarino","year":"2001","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2007.09.005_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0735-1097(00)00687-2","article-title":"Pulse pressure and risk for myocardial infarction and heart failure in the elderly","volume":"36","author":"Vaccarino","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ccl.2007.09.005_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM197210192871601","article-title":"Role of blood pressure in the development of congestive heart failure: The Framingham study","volume":"287","author":"Kannel","year":"1972","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ccl.2007.09.005_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9149(90)90807-D","article-title":"Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed","volume":"65","author":"Cooper","year":"1990","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ccl.2007.09.005_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-117-10-831","article-title":"The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease","volume":"117","author":"Ghali","year":"1992","journal-title":"Ann Intern Med"},{"issue":"22","key":"10.1016\/j.ccl.2007.09.005_bib12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ccl.2007.09.005_bib13","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1388-9842(03)00052-7","article-title":"Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) programme","volume":"5","author":"McMurray","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ccl.2007.09.005_bib15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0735-1097(01)01567-4","article-title":"Heart failure with preserved systolic function: a different natural history?","volume":"38","author":"Senni","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ccl.2007.09.005_bib16","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2796.2001.00801.x","article-title":"Heart failure in the general population of men: morbidity, risk factors and prognosis","volume":"249","author":"Wilhelmsen","year":"2001","journal-title":"J Intern Med"},{"issue":"7","key":"10.1016\/j.ccl.2007.09.005_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1970.03170330025003","article-title":"Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg","volume":"213","year":"1970","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccl.2007.09.005_bib19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.mcna.2004.06.002","article-title":"Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure","volume":"88","author":"Izzo","year":"2004","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1997.03550030052033","article-title":"Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: SHEP Cooperative Research Group","volume":"278","author":"Kostis","year":"1997","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccl.2007.09.005_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1054\/jcaf.2002.0805333","article-title":"Prevention of heart failure","volume":"8","author":"Baker","year":"2002","journal-title":"J Card Fail"},{"issue":"9118","key":"10.1016\/j.ccl.2007.09.005_bib22","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure\u00a0lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"7160","key":"10.1016\/j.ccl.2007.09.005_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"issue":"2 Suppl","key":"10.1016\/j.ccl.2007.09.005_bib24","first-page":"III48","article-title":"Heart failure with normal ejection fraction: the V-HeFT Study. Veterans Administration Cooperative Study Group","volume":"81","author":"Cohn","year":"1990","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccl.2007.09.005_bib25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0002-9149(84)80207-6","article-title":"Congestive heart failure with normal systolic function","volume":"54","author":"Dougherty","year":"1984","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2007.09.005_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0002-9343(83)90403-5","article-title":"Congestive heart failure: echocardiographic insights","volume":"75","author":"Echeverria","year":"1983","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.ccl.2007.09.005_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/0002-9149(85)90741-6","article-title":"Intact systolic left ventricular function in clinical congestive heart failure","volume":"55","author":"Soufer","year":"1985","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ccl.2007.09.005_bib29","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2007.09.005_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.106.668921","article-title":"Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study","volume":"115","author":"Drukteinis","year":"2007","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccl.2007.09.005_bib31","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0894-7317(98)80005-9","article-title":"Left ventricular diastolic properties of hypertensive patients measured by pulsed tissue Doppler imaging","volume":"11","author":"Oki","year":"1998","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"10.1016\/j.ccl.2007.09.005_bib32","doi-asserted-by":"crossref","first-page":"H767","DOI":"10.1152\/ajpheart.00047.2004","article-title":"Cardiac structural and functional responses to salt loading in SHR","volume":"287","author":"Ahn","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ccl.2007.09.005_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4615-5385-4_10","article-title":"Salt sensitivity and left ventricular hypertrophy","volume":"432","author":"Coca","year":"1997","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.ccl.2007.09.005_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/01.RES.22.1.11","article-title":"Effects of chronic excess salt ingestion: modification of experimental hypertension in the rat by variations in the diet","volume":"22","author":"Dahl","year":"1968","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.ccl.2007.09.005_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.jhh.1000893","article-title":"Early abnormalities in left ventricular diastolic function of sodium-sensitive hypertensive patients","volume":"13","author":"Musiari","year":"1999","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ccl.2007.09.005_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004937","article-title":"Effect of longer-term modest salt reduction on blood pressure","volume":"3","author":"He","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ccl.2007.09.005_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.HYP.0000171474.84969.7a","article-title":"Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension","volume":"46","author":"He","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ccl.2007.09.005_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet: DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib39","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.CIR.89.3.1041","article-title":"Correlates of left ventricular mass in a population sample aged 36 to 37 years: focus on lifestyle and salt intake","volume":"89","author":"Kupari","year":"1994","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ccl.2007.09.005_bib40","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/archinte.1997.00440420077006","article-title":"Salt: a perpetrator of hypertensive target organ disease?","volume":"157","author":"Messerli","year":"1997","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.ccl.2007.09.005_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/01.CIR.78.4.951","article-title":"Dietary salt intake: a determinant of cardiac involvement in essential hypertension","volume":"78","author":"Schmieder","year":"1988","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2007.09.005_bib42","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/00004872-198812040-00043","article-title":"Sodium intake modulates left ventricular hypertrophy in essential hypertension","volume":"6","author":"Schmieder","year":"1988","journal-title":"J\u00a0Hypertens Suppl"},{"issue":"6","key":"10.1016\/j.ccl.2007.09.005_bib43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1053\/euhj.1997.0854","article-title":"Impact of dietary sodium intake on left ventricular diastolic filling in early essential hypertension","volume":"19","author":"Langenfeld","year":"1998","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ccl.2007.09.005_bib44","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.HYP.0000167152.98618.4b","article-title":"Management of prehypertension","volume":"45","author":"Svetkey","year":"2005","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.ccl.2007.09.005_bib45","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.289.16.2083","article-title":"Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial","volume":"289","author":"Appel","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ccl.2007.09.005_bib46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-144-7-200604040-00007","article-title":"Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial","volume":"144","author":"Elmer","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ccl.2007.09.005_bib47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.HYP.0000132768.19056.33","article-title":"The dietary sodium-blood pressure plot \u201cstiffens.\u201d","volume":"44","author":"Bagrov","year":"2004","journal-title":"Hypertension"},{"issue":"16","key":"10.1016\/j.ccl.2007.09.005_bib48","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group","volume":"336","author":"Appel","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ccl.2007.09.005_bib49","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/01.HYP.0000102864.05174.E8","article-title":"How far should salt intake be reduced?","volume":"42","author":"He","year":"2003","journal-title":"Hypertension"},{"issue":"6442","key":"10.1016\/j.ccl.2007.09.005_bib50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/bmj.289.6442.406","article-title":"Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial","volume":"289","author":"Erwteman","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"10","key":"10.1016\/j.ccl.2007.09.005_bib51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00004872-198810000-00004","article-title":"Effects of a low-sodium high-potassium salt in hypertensive patients treated with metoprolol: a multicentre study","volume":"6","author":"Suppa","year":"1988","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.ccl.2007.09.005_bib52","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3109\/10641968409039583","article-title":"Effect of dietary sodium restriction on patients receiving antihypertensive medication","volume":"6","author":"Carney","year":"1984","journal-title":"Clin Exp Hypertens A"},{"issue":"2","key":"10.1016\/j.ccl.2007.09.005_bib53","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ki.1981.126","article-title":"Sodium intake and renal responses to captopril in normal man and in essential hypertension","volume":"20","author":"Hollenberg","year":"1981","journal-title":"Kidney Int"},{"issue":"6571","key":"10.1016\/j.ccl.2007.09.005_bib54","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.294.6571.531","article-title":"Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study","volume":"294","author":"MacGregor","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"2","key":"10.1016\/j.ccl.2007.09.005_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.0954-6820.1988.tb15777.x","article-title":"Additive effects of moderate dietary salt reduction and captopril in hypertension","volume":"223","author":"Kristinsson","year":"1988","journal-title":"Acta Med Scand"},{"issue":"Suppl 10","key":"10.1016\/j.ccl.2007.09.005_bib56","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/00005344-198710100-00021","article-title":"Calcium antagonists and sodium balance: effect of changes in sodium intake and of the addition of a thiazide diuretic on the blood pressure lowering effect of nifedipine","volume":"10","author":"Cappuccio","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3B","key":"10.1016\/j.ccl.2007.09.005_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0002-9343(87)90206-3","article-title":"Sodium intake, high blood pressure, and calcium channel blockers","volume":"82","author":"MacGregor","year":"1987","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ccl.2007.09.005_bib58","doi-asserted-by":"crossref","first-page":"S652","DOI":"10.1097\/00004872-198812040-00205","article-title":"Interaction of slow-channel calcium blocking drugs with sodium restriction, diuretics and angiotensin converting enzyme inhibitors","volume":"6","author":"Morgan","year":"1988","journal-title":"J Hypertens Suppl"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib59","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.HYP.35.3.838","article-title":"Progressive resistance exercise and resting blood pressure: a meta-analysis of randomized controlled trials","volume":"35","author":"Kelley","year":"2000","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ccl.2007.09.005_bib60","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-136-7-200204020-00006","article-title":"Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials","volume":"136","author":"Whelton","year":"2002","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ccl.2007.09.005_bib61","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0026-0495(98)90281-5","article-title":"Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men","volume":"47","author":"Dengel","year":"1998","journal-title":"Metabolism"},{"issue":"22","key":"10.1016\/j.ccl.2007.09.005_bib62","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199511303332204","article-title":"Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension","volume":"333","author":"Kokkinos","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib63","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00004872-199103000-00013","article-title":"Physical exercise in the management of hypertension: a consensus statement by the World Hypertension League","volume":"9","author":"World Hypertension League","year":"1991","journal-title":"J\u00a0Hypertens"},{"issue":"13","key":"10.1016\/j.ccl.2007.09.005_bib64","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/archinte.160.13.1947","article-title":"Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning","volume":"160","author":"Blumenthal","year":"2000","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.ccl.2007.09.005_bib65","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/HYPERTENSIONAHA.107.087718","article-title":"Exercise as a physiologic intervention to counteract hypertension: can a good idea go bad?","volume":"50","author":"Sarma","year":"2007","journal-title":"Hypertension"},{"issue":"7433","key":"10.1016\/j.ccl.2007.09.005_bib66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bmj.37938.645220.EE","article-title":"Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)","volume":"328","author":"Piepoli","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ccl.2007.09.005_bib67","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1378\/chest.123.1.244","article-title":"The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing","volume":"123","author":"Dart","year":"2003","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccl.2007.09.005_bib68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.CIR.0000072346.56728.E4","article-title":"Sleep-disordered breathing and cardiovascular disease","volume":"108","author":"Wolk","year":"2003","journal-title":"Circulation"},{"issue":"9311","key":"10.1016\/j.ccl.2007.09.005_bib69","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ccl.2007.09.005_bib70","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents","volume":"328","author":"Materson","year":"1993","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ccl.2007.09.005_bib71","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"4","author":"Cushman","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"16","key":"10.1016\/j.ccl.2007.09.005_bib72","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.289.16.2073","article-title":"Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial","volume":"289","author":"Black","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ccl.2007.09.005_bib73","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0735-1097(95)00606-0","article-title":"Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials","volume":"27","author":"Moser","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"9290","key":"10.1016\/j.ccl.2007.09.005_bib74","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","article-title":"Cardiovascular protection and blood pressure reduction: a meta-analysis","volume":"358","author":"Staessen","year":"2001","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ccl.2007.09.005_bib75","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","author":"ALLHAT investigators","year":"2002","journal-title":"JAMA"},{"issue":"9386","key":"10.1016\/j.ccl.2007.09.005_bib76","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ccl.2007.09.005_bib78","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ccl.2007.09.005_bib79","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/0003-4819-138-7-200304010-00010","article-title":"Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy","volume":"138","author":"Berl","year":"2003","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ccl.2007.09.005_bib80","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/jama.288.12.1491","article-title":"Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy","volume":"288","author":"Kjeldsen","year":"2002","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.ccl.2007.09.005_bib81","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib82","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ndt\/13.3.564","article-title":"Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)","volume":"13","author":"Schmieder","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib83","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.CIR.91.3.698","article-title":"Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)","volume":"91","author":"Liebson","year":"1995","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ccl.2007.09.005_bib84","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.95.8.2007","article-title":"Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents","volume":"95","author":"Gottdiener","year":"1997","journal-title":"Circulation"},{"issue":"6824","key":"10.1016\/j.ccl.2007.09.005_bib85","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party","volume":"304","year":"1992","journal-title":"BMJ"},{"issue":"9489","key":"10.1016\/j.ccl.2007.09.005_bib86","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"issue":"9496","key":"10.1016\/j.ccl.2007.09.005_bib87","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(05)67573-3","article-title":"Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis","volume":"366","author":"Lindholm","year":"2005","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ccl.2007.09.005_bib88","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.279.23.1903","article-title":"Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review","volume":"279","author":"Messerli","year":"1998","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ccl.2007.09.005_bib89","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.1988.03720130040027","article-title":"Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY study","volume":"259","author":"Wikstrand","year":"1988","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ccl.2007.09.005_bib90","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3109\/10641969309037083","article-title":"MRC trial of treatment in elderly hypertensives","volume":"15","author":"Lever","year":"1993","journal-title":"Clin Exp Hypertens"},{"issue":"8693","key":"10.1016\/j.ccl.2007.09.005_bib91","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"issue":"9446","key":"10.1016\/j.ccl.2007.09.005_bib92","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(04)17355-8","article-title":"Atenolol in hypertension: is it a wise choice?","volume":"364","author":"Carlberg","year":"2004","journal-title":"Lancet"},{"issue":"7A","key":"10.1016\/j.ccl.2007.09.005_bib93","doi-asserted-by":"crossref","first-page":"32L","DOI":"10.1016\/j.amjcard.2006.07.017","article-title":"Controlled-release carvedilol in the treatment of essential hypertension","volume":"98","author":"Weber","year":"2006","journal-title":"Am J Cardiol"},{"issue":"18","key":"10.1016\/j.ccl.2007.09.005_bib94","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccl.2007.09.005_bib95","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2710.2006.00718.x","article-title":"Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension","volume":"31","author":"Peter","year":"2006","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.ccl.2007.09.005_bib96","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ccl.2007.09.005_bib97","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions: the SOLVD Investigators","volume":"327","author":"SOLVD investigators","year":"1992","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ccl.2007.09.005_bib98","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-141-8-200410190-00009","article-title":"Antihypertensive drug therapy in black patients","volume":"141","author":"Brewster","year":"2004","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.ccl.2007.09.005_bib99","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/jama.293.13.1595","article-title":"Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril","volume":"293","author":"Wright","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccl.2007.09.005_bib100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cardfail.2006.01.013","article-title":"Spironolactone treatment and clinical outcomes in patients with systolic dysfunction and mild heart failure symptoms: a retrospective analysis","volume":"12","author":"Baliga","year":"2006","journal-title":"J Card Fail"},{"issue":"10","key":"10.1016\/j.ccl.2007.09.005_bib101","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ccl.2007.09.005_bib102","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ccl.2007.09.005_bib103","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJM199610103351504","article-title":"Effect of amlodipine on morbidity and mortality in severe chronic heart failure: Prospective Randomized Amlodipine Survival Evaluation Study Group","volume":"335","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ccl.2007.09.005_bib104","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure: the SOLVD investigators","volume":"325","author":"SOLVD investigators","year":"1991","journal-title":"N Engl J Med"},{"issue":"8875","key":"10.1016\/j.ccl.2007.09.005_bib105","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure: the Acute Infarction Ramipril Efficacy (AIRE) study investigators","volume":"342","author":"AIRE investigators","year":"1993","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ccl.2007.09.005_bib106","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction: Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"Kober","year":"1995","journal-title":"N Engl J Med"},{"issue":"9169","key":"10.1016\/j.ccl.2007.09.005_bib107","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","author":"MERIT-HF study group","year":"1999","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ccl.2007.09.005_bib108","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"issue":"9146","key":"10.1016\/j.ccl.2007.09.005_bib109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","author":"CIBIS study group","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2007.09.005_bib110","doi-asserted-by":"crossref","unstructured":"Fagard R, Staessen JA, et\u00a0al. On-treatment diastolic blood pressure and prognosis in systolic hypertension. 2007;167(17):1884\u201391.","DOI":"10.1001\/archinte.167.17.1884"},{"issue":"19","key":"10.1016\/j.ccl.2007.09.005_bib111","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccl.2007.09.005_bib112","first-page":"141","article-title":"Maximizing cardiorenal benefit in the management of hypertension: achieve blood pressure goals","volume":"1","author":"Bakris","year":"1999","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"10","key":"10.1016\/j.ccl.2007.09.005_bib113","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.ccl.2007.09.005_bib114","first-page":"B54","article-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes","volume":"23","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ccl.2007.09.005_bib115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ccl.2007.09.005_bib116","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","article-title":"Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study","volume":"163","author":"Bakris","year":"2003","journal-title":"Arch Intern Med"},{"issue":"7160","key":"10.1016\/j.ccl.2007.09.005_bib117","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865107001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865107001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T17:02:20Z","timestamp":1557075740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865107001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0733865107001014"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2007.09.005","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}